GlassScriptPhysician profile
Samrat Khanna
NPI 1053629881
$20,761.66
in general payments reported to CMS, 2019-2025
50 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,020 · 2020: $743 · 2021: $1,812 · 2022: $2,006 · 2023: $1,791 · 2024: $10K · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,169 · Food and Beverage: $6,277 · Travel and Lodging: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,168.99 |
| Food and Beverage | $6,276.58 |
| Travel and Lodging | $735.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,880.64 | 2023-2024 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $2,463.79 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,986.98 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,146.85 | 2019-2025 | Ofev, Jardiance, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $830.12 | 2019-2025 | |
| Mylan Specialty L.P. | $647.84 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $620.50 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $576.20 | 2020-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $469.06 | 2021-2025 | Smartvest |
| Mallinckrodt Hospital Products INC. | $371.64 | 2021-2025 | Acthar |
| Genentech USA, INC. | $369.41 | 2019-2023 | Xolair, Esbriet |
| Janssen Pharmaceuticals, INC | $318.27 | 2021-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $259.49 | 2021-2025 | Glassia, Hyqvia |
| Genzyme Corporation | $247.54 | 2019-2025 | |
| Baxter Healthcare | $226.39 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $213.48 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Actelion Pharmaceuticals US, INC. | $190.67 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $183.85 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $166.30 | 2021-2025 | Tezspire, Tavneos |
| Inogen, INC. | $96.07 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen At Home Stationary Concentrator |
| Verona Pharma, INC. | $90.98 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $89.40 | 2022 | |
| Novartis Pharmaceuticals Corporation | $87.27 | 2019-2020 | |
| Insmed, INC. | $83.68 | 2023-2025 | Arikayce |
| Viatris Specialty LLC | $79.16 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Advanced Respiratory, INC | $77.28 | 2019-2021 | |
| Chiesi USA, INC. | $74.78 | 2024-2025 | Cleviprex, Kengreal |
| Axsome Therapeutics, INC. | $70.89 | 2024-2025 | Sunosi |
| Pulmonx Corporation | $63.01 | 2021-2022 | |
| Harmony Biosciences LLC | $59.67 | 2023-2024 | Wakix |
| Alexion Pharmaceuticals, INC. | $53.60 | 2020-2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $48.46 | 2019 | |
| Inspire Medical Systems, INC. | $47.52 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $46.29 | 2021-2023 | |
| Pfizer INC. | $46.04 | 2019-2023 | |
| Ani Pharmaceuticals, INC. | $45.04 | 2024 | Purified Cortrophin Gel |
| Lilly USA, LLC | $43.85 | 2025 | Zepbound |
| Sunovion Pharmaceuticals INC. | $40.50 | 2019 | |
| Ambu INC. | $37.49 | 2021 | |
| Tactile Systems Technology INC | $37.47 | 2025 | Flexitouch Plus, Nimbl |
| Phathom Pharmaceuticals, INC. | $30.49 | 2025 | Voquezna |
| Shire North American Group INC | $29.33 | 2019 | |
| Resmed Corp | $25.79 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.53 | 2025 | Eliquis |
| Ultragenyx Pharmaceutical INC. | $19.25 | 2021 | |
| La Jolla Pharmaceutical Company | $18.76 | 2019 | |
| Adma Biomanufacturing LLC | $17.46 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.46 | 2023 | Xifaxan |
| Novo Nordisk INC | $15.13 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samrat Khanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.